Skip to main content
Premium Trial:

Request an Annual Quote

Saad Usmani

Saad Usmani has been appointed Acting CMO of SkylineDx, where he will lead the overall clinical vision of the Dutch cancer molecular diagnostics firm. Usmani is currently the director of clinical research (hematologic malignancies) and director of plasma cell disorders at Carolinas HealthCare System's Levine Cancer Institute. He previously was director of developmental therapeutics at the University of Arkansas.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.